Anatomical and Physiological Characterisation of the Gut Endocrine Cells in Healthy and in Patients With Type 2 Diabetes
NCT03044860 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2017-02-15
Summary
Investigation of the anatomical distribution of enteroendocrine cells by a systematic approach along the entire human intestinal tract in healthy individuals and patients with type 2 diabetes.
Conditions
- Type2 Diabetes
Interventions
- PROCEDURE
-
Double-balloon enteroscopy (DBE) with biopsy retrieval
With the use of a double-balloon enteroscopy device, study participants underwent upper and lower enteroscopies with mucosal biopsy mucosal biopsy retrieval from every \~30 cm of the small intestine and specific locations in the large intestine
Sponsors & Collaborators
-
University Hospital, Gentofte, Copenhagen
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
More Related Trials
-
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
NCT06267391 ·Status: RECRUITING ·Phase: NA
-
The Anatomical Location, Cellular Origin and Molecular Basis of Gut-derived Glucagon Secretion
NCT03181191 ·Status: COMPLETED ·Phase: NA
-
Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes
NCT02497313 ·Status: COMPLETED ·Phase: NA
-
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes
NCT00704795 ·Status: UNKNOWN
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Bile Acid-induced GLP-secretion. A Study in Cholecystectomized Subjects
NCT01251510 ·Status: COMPLETED
-
Study of Endocrine-Related Conditions and Physiology
NCT03867448 ·Status: RECRUITING
-
Involvement of Steatosis-induced Glucagon Resistance in Hyperglucagonaemia
NCT02337660 ·Status: COMPLETED ·Phase: NA
-
The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones
NCT02360878 ·Status: COMPLETED
-
The Influence of Cholecystectomy on Secretion of Incretin Hormones
NCT03305783 ·Status: COMPLETED
-
Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 Diabetes
NCT02368704 ·Status: UNKNOWN
-
The Effect of an Acute Increase in Plasma IL-6 on Glucose Tolerance When a Meal is Administered Intraduodenally
NCT03660332 ·Status: COMPLETED ·Phase: NA
-
The Role of the Kidneys and Liver in the Elimination of Glucagon
NCT05056584 ·Status: COMPLETED ·Phase: NA
-
Trial Investigating Efficacy of G-POEM
NCT05830994 ·Status: UNKNOWN ·Phase: NA
-
Performance of Six Equations for Estimating Resting Energy Expenditure in Patients With Type 2 Diabetes
NCT04484883 ·Status: COMPLETED
-
GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
NCT01988545 ·Status: UNKNOWN ·Phase: NA
-
Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion
NCT02445508 ·Status: COMPLETED ·Phase: NA
-
Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome
NCT00673751 ·Status: UNKNOWN ·Phase: NA
-
Effect of Bile Acids on GLP-1 Secretion
NCT01666223 ·Status: COMPLETED ·Phase: NA
-
The Acute Effects of Low-dose TNF-α on Glucose Metabolism and β-cell Function in Humans
NCT01953393 ·Status: COMPLETED ·Phase: NA
-
Role of the Liver in Glucose Homeostasis Using Metabolic Imaging
NCT04352738 ·Status: COMPLETED
-
Safety and Feasibility of Novel Therapy for Duodenal Mucosal Regeneration for Type II Diabetes
NCT05014204 ·Status: COMPLETED ·Phase: NA
-
Separate and Combined Extrapancreatic Effects of the Incretin Hormones
NCT05177653 ·Status: COMPLETED ·Phase: NA
-
The Role of the Duodenum in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Mellitus
NCT00568620 ·Status: COMPLETED ·Phase: NA
-
Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion
NCT03223129 ·Status: COMPLETED ·Phase: NA